TRIO has shown effectiveness and safety in patients with T2DM initiating BI after OAD failure with the assistance of WeChat digital platform, which is consistent with previous single-arm studies incorporating digital tools conducted in patients with prediabetes [15,18] and patients treated with premixed insulin and BI [14,19,20]. This evidence concerns the gene INS and prediabetes syndrome.